Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy

The Prostate ◽

10.1002/pros.24267 ◽

2021 ◽

Author(s):

Anne M. A. Tryggestad ◽

Karol Axcrona ◽

Ulrika Axcrona ◽

Iris Bigalke ◽

Bjørn Brennhovd ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Radical Prostatectomy ◽

Phase I ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Abstract CT016: A first in man phase I/II adjuvant dendritic cell vaccine study in high-risk prostate cancer patients following radical surgery reduce the incidence of biochemical relapse

10.1158/1538-7445.am2018-ct016 ◽

2018 ◽

Author(s):

Anne Merete Tryggestad ◽

Iris Bigalke ◽

Karol Axcrona ◽

Bjørn Brennhovd ◽

T Kirsti Hønnåshagen ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Biochemical Relapse ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

Cytotherapy ◽

10.1016/j.jcyt.2017.02.025 ◽

2017 ◽

Vol 19 (5) ◽

pp. S15 ◽

Cited By ~ 1

Author(s):

A.A. Tryggestad ◽

I. Bigalke ◽

K. Axcrona ◽

E. Inderberg ◽

G. Skorstad ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

C150 Long-term outcome for very high-risk prostate cancer treated primary with radical prostatectomy

European Urology Supplements ◽

10.1016/s1569-9056(13)61998-3 ◽

2013 ◽

Vol 12 (4) ◽

pp. e1258, C150

Author(s):

C.K. Kobajlo ◽

J.A. Adamowicz ◽

Z.W. Wolski

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Term Outcome ◽

Long Term Outcome ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Very High

Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation

Urologia Internationalis ◽

10.1159/000277593 ◽

2010 ◽

Vol 84 (2) ◽

pp. 164-173 ◽

Cited By ~ 30

Author(s):

Martin Spahn ◽

Christel Weiss ◽

Pia Bader ◽

Philipp Ströbel ◽

Elmar W. Gerharz ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Androgen Deprivation ◽

Term Outcome ◽

Long Term Outcome ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

1013 Long-term outcomes of very high risk prostate cancer patients treated with radical prostatectomy with or without adjuvant treatments. Results of a competing risks, multiinstitutional analysis

European Urology Supplements ◽

10.1016/s1569-9056(15)61001-6 ◽

2015 ◽

Vol 14 (2) ◽

pp. e1013-e1013a

Author(s):

M. Bianchi ◽

R.J. Karnes ◽

S. Joniau ◽

G. Gandaglia ◽

M. Spahn ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Cancer Patients ◽

Competing Risks ◽

Long Term Outcomes ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Very High

Long-term oncological results of treatment for high-risk prostate cancer using radical prostatectomy in a cancer hospital

Actas Urológicas Españolas (English Edition) ◽

10.1016/j.acuroe.2018.07.003 ◽

2018 ◽

Vol 42 (8) ◽

pp. 507-515

Author(s):

J. Rubio-Briones ◽

M. Ramírez-Backhaus ◽

A. Gómez-Ferrer ◽

C. Mir ◽

J. Domínguez-Escrig ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

High Risk Prostate Cancer ◽

Results Of Treatment ◽

Cancer Hospital ◽

Risk Prostate Cancer ◽

Oncological Results

Safety, objective response rate and long-term oncologic outcomes of docetaxel neoadjuvant chemotherapy followed by radical prostatectomy for patients with intermediate- and high-risk prostate cancer: a retrospective singlecenter study

European Urology Supplements ◽

10.1016/s1569-9056(14)50043-7 ◽

2014 ◽

Vol 13 (2) ◽

pp. e1189

Author(s):

A. Nosov ◽

S. Petrov ◽

S. Reva ◽

E. Mamijev ◽

R. Novikov

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Neoadjuvant Chemotherapy ◽

Response Rate ◽

Objective Response ◽

Oncologic Outcomes ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

MP47-13 COMPARISON BETWEEN MID-TERM OUTCOMES OF HIGH-DOSE-RATE BRACHYTHERAPY WITH EXTERNAL-BEAM RADIOTHERAPY COMBINED WITH LONG-TERM ANDROGEN DEPRIVATION THERAPY AND RADICAL PROSTATECTOMY IN PATIENTS WITH HIGH-RISK PROSTATE CANCER.

The Journal of Urology ◽

10.1016/j.juro.2017.02.1473 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Hajime Onuma ◽

Takahiro Kimura ◽

Kojiro Tashiro ◽

Yasutoshi Yoshiyama ◽

Masahito Kido ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

External Beam Radiotherapy ◽

High Dose Rate ◽

High Dose ◽

External Beam ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

LONG-TERM SURVIVAL AFTER RADICAL PROSTATECTOMY FOR PATIENTS WITH HIGH RISK PROSTATE CANCER IN THE PSA ERA

The Journal of Urology ◽

10.1016/s0022-5347(08)61626-2 ◽

2008 ◽

Vol 179 (4S) ◽

pp. 552-553 ◽

Cited By ~ 1

Author(s):

Stephen A Boorjian ◽

R Jeffrey Karnes ◽

Laureano J Rangel ◽

Eric J Bergstralh ◽

Michael L Blute

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Term Survival ◽

Long Term Survival ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Impact of the 2014 International Society of Urological Pathology Grading System on Concept of High-Risk Prostate Cancer: Comparison of Long-Term Oncological Outcomes in Patients Undergoing Radical Prostatectomy

Frontiers in Oncology ◽

10.3389/fonc.2019.01272 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 1

Author(s):

Daimantas Milonas ◽

Žilvinas Venclovas ◽

Inga Gudinaviciene ◽

Stasys Auskalnis ◽

Kristina Zviniene ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

International Society ◽

Grading System ◽

Oncological Outcomes ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer